Šalis: Pietų Afrika
kalba: anglų
Šaltinis: South African Health Products Regulatory Authority (SAHPRA)
Janssen
INDICATIONS [/za_1290.html#1] [/za_1290.html#1] [/za_1290.html#1] CONTRA-INDICATIONS [/za_1290.html#1] [/za_1290.html#1] DOSAGE [/za_1290.html#1] [/za_1290.html#1] SIDE-EFFECTS [/za_1290.html#1] [/za_1290.html#1] [/za_1290.html#1] PREGNANCY [/za_1290.html#1] [/za_1290.html#1] OVERDOSE [/za_1290.html#1] IDENTIFICATION [/za_1290.html#1] [/za_1290.html#1] PATIENT INFORMATION IMODIUM® SYRUP SCHEDULING STATUS: Schedule 2 PROPRIETARY NAME (and dosage form): IMODIUM ® SYRUP COMPOSITION Each mL contains 0,2 mg LOPERAMIDE hydrochloride. Methylparaben 0,072% m/v and propylparaben 0,008% m/v as preservatives. PHARMACOLOGICAL CLASSIFICATION A.11.9 Medicines acting on gastro-intestinal tract. Anti-diarrhoeals. PHARMACOLOGICAL ACTION IMODIUM inhibits hypermotility by direct action on the bowel wall. Its inhibition of peristalsis is the result of decreasing the activity of both the longitudinal muscles (preparatory and reflex phases) and the circular muscles (reflex phase). IMODIUM normalizes the stool in both acute and chronic diarrhoea. IMODIUM is incompletely absorbed from the gut, and it is almost completely metabolized in the liver where it is conjugated and excreted via the bile. IMODIUM is mainly eliminated via the faeces. INDICATIONS ADULTS AND CHILDREN 6 YEARS AND OLDER: IMODIUM is indicated for the control and symptomatic relief of acute and chronic nonspecific diarrhoea and inhibits peristalsis and slows intestinal transit time in patients with ileostomies, colostomies and other intestinal resections. CHILDREN BELOW 6 YEARS OF AGE: IMODIUM is indicated for inhibition of peristalsis and slowing intestinal transit time. CONTRA-INDICATIONS IMODIUM is contra-indicated in patients with a known hypersensitivity to the medicine. IMODIUM is contra-indicated in infants under Perskaitykite visą dokumentą